Phase CML

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-05-12
Clinical Trial Update: Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment [Phase 2]
Phase 2 clinical trial evaluating the value of adding pioglitazone to treatment in chronic myeloid leukemia with BCR-ABL positivity.